BEACHWOOD, Ohio--(BUSINESS WIRE)--DDR Corp. (NYSE:DDR) today announced that it has completed the previously announced spin-off of Retail Value Inc. (“RVI”), which is now an independent, publicly ...
The DNA Damage Response (DDR) field is entering a defining new phase. With PARP inhibitors firmly established in the clinic, attention is turning toward next-generation DDR targets – including ATR, ...